| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Laboratory of Hepatitis and Related Emerging Agents, CBER, Food and Drug Administration, Bethesda, Maryland 20892,1 Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115,2 Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611,3 Division of Immunology, Karp Laboratories, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 021154
Received 24 July 2006/ Accepted 7 January 2007
The hepatitis A virus cellular receptor 1 (HAVCR1/TIM1), a member of the T-cell immunoglobulin mucin (TIM) family, is an important atopy susceptibility gene in humans. The exact natural function of HAVCR1/TIM1 and the inverse association between HAV infection and prevention of atopy are not well understood. To identify natural ligands of human HAVCR1/TIM1, we used an expression cloning strategy based on the binding of dog cells transfected with a human lymph node cDNA library to a HAVCR1/TIM1 Fc fusion protein. The transfected cells that bound to the human HAVCR1/TIM1 Fc contained cDNA of human immunoglobulin alpha 1 heavy (Ig
1) and lambda light (Ig
) chain and secreted human IgA1
antibody that bound to the cell surface. Cotransfection of the isolated Ig
1 and Ig
cDNAs to naïve dog cells resulted in the secretion of IgA1
that bound to HAVCR1/TIM1 Fc but not to a poliovirus receptor Fc fusion protein in a capture enzyme-linked immunosorbent assay. The interaction of HAVCR1/TIM1 with IgA was inhibited by monoclonal antibodies (MAbs) against Ig
1 and Ig
, excess IgA1
, or anti-HAVCR1/TIM1 MAb. IgA did not inhibit HAV infection of African green monkey cells, suggesting that the IgA and the virus binding sites are in different epitopes on HAVCR1/TIM1. IgA enhanced significantly the neutralization of HAV by HAVCR1/TIM1 Fc. Our results indicate that IgA1
is a specific ligand of HAVCR1/TIM1 and that their association has a synergistic effect in virus-receptor interactions.
Published ahead of print on 17 January 2007.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|